Related Experiment Video
Updated: Jun 27, 2026
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Utilization of Intravenous Iron Therapy and Red Blood Cell Transfusion in Emergency Department Patients with Anemia:
Sung-Joon Park1,2, Min Joung Kim3, Young-Hoon Yoon1,2
1Department of Emergency Medicine, College of Medicine, Korea University, Seoul 02841, Republic of Korea.
Background/Objectives: Anemia is frequently encountered in emergency departments (EDs). Although intravenous (IV) iron can be used as an alternative or adjunct to red blood cell (RBC) transfusion in selected hemodynamically stable patients, its use in the ED remains limited. This study described IV iron utilization and RBC transfusion patterns in ED patients with anemia and evaluated their associations with clinical outcomes. Methods: We conducted a single-center retrospective cohort study of patients who presented to a tertiary ED with hemoglobin (Hb) ≤ 10 g/dL between January 2019 and December 2021. Patients were categorized according to receipt of IV iron in the ED. Baseline characteristics, laboratory findings, transfusion practice, hospital length of stay (LOS), ICU admission, and in-hospital mortality were compared between groups. Results: Among 3340 patients, 89 (2.7%) received IV iron in the ED. IV iron recipients were older and had lower Hb levels than non-recipients. Gastrointestinal disorders were more frequent in the IV iron group (68.5% vs. 19.9%), and IV iron was commonly administered with ED RBC transfusion. ED transfusion (69.7% vs. 11.1%) and ICU admission (24.7% vs. 15.7%) were more frequent in the IV iron group. Among patients with available ferritin and transferrin saturation (TSAT), IV iron recipients had lower ferritin levels and more frequently showed ferritin-based or combined ferritin/TSAT findings suggestive of iron deficiency. In-hospital mortality was similar between groups (5.6% vs. 5.7%). Among hospitalized patients, median LOS was shorter in the IV iron group than in the non-IV iron group (6.6 vs. 9.7 days). Conclusions: IV iron was infrequently administered in ED patients with Hb ≤ 10 g/dL and was used mainly as an adjunct to RBC transfusion in older patients with gastrointestinal causes of anemia. Its association with shorter LOS should be interpreted cautiously. Structured ED-based anemia evaluation may help optimize IV iron use in selected patients.
Background/Objectives: Anemia is frequently encountered in emergency departments (EDs). Although intravenous (IV) iron can be used as an alternative or adjunct to red blood cell (RBC) transfusion in selected hemodynamically stable patients, its use in the ED remains limited. This study described IV iron utilization and RBC transfusion patterns in ED patients with anemia and evaluated their associations with clinical outcomes. Methods: We conducted a single-center retrospective cohort study of patients who presented to a tertiary ED with hemoglobin (Hb) ≤ 10 g/dL between January 2019 and December 2021. Patients were categorized according to receipt of IV iron in the ED. Baseline characteristics, laboratory findings, transfusion practice, hospital length of stay (LOS), ICU admission, and in-hospital mortality were compared between groups. Results: Among 3340 patients, 89 (2.7%) received IV iron in the ED. IV iron recipients were older and had lower Hb levels than non-recipients. Gastrointestinal disorders were more frequent in the IV iron group (68.5% vs. 19.9%), and IV iron was commonly administered with ED RBC transfusion. ED transfusion (69.7% vs. 11.1%) and ICU admission (24.7% vs. 15.7%) were more frequent in the IV iron group. Among patients with available ferritin and transferrin saturation (TSAT), IV iron recipients had lower ferritin levels and more frequently showed ferritin-based or combined ferritin/TSAT findings suggestive of iron deficiency. In-hospital mortality was similar between groups (5.6% vs. 5.7%). Among hospitalized patients, median LOS was shorter in the IV iron group than in the non-IV iron group (6.6 vs. 9.7 days). Conclusions: IV iron was infrequently administered in ED patients with Hb ≤ 10 g/dL and was used mainly as an adjunct to RBC transfusion in older patients with gastrointestinal causes of anemia. Its association with shorter LOS should be interpreted cautiously. Structured ED-based anemia evaluation may help optimize IV iron use in selected patients.
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
02:45Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:27Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...